Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC

Samsung Medical Center

Status: Unknown

Conditions: Lung Neoplasms

Study type: Observational

Funder types: Other

Identifiers

NCT04922073

2021-04-150

Details and patient eligibility

About

The aim of the study is to assess the practical usability of EGFR mutation detection in ctDNA from early NSCLC.

Enrollment: 150 estimated patients

Sex: All

Ages: 20 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with clinical stage IB to IIIA Non-small Cell Lung Cancer
• Patients with resectable lung cancer
• One of followings: 1) Never-smokers or ex-smokers who quit 10 years ago, 2) Female 3) Subsolid nodule in chest CT 4) Biopsy-proven adenocarcinoma

Exclusion criteria

• Patients with metastatic lung cancer (Stage IIIB-IV)
• Patients who underwent chemotherapy or radiotherapy
• Patients with other malignancies